Deliang Wang

Huzhou University

Papers

1

Total Citations

37

H-Index

1

About

Deliang Wang is a pioneering researcher at the forefront of biomedical engineering and nanotheranostics, with a core focus on developing advanced phototherapy platforms for cancer treatment. His most influential work centers on the innovative integration of aggregation-induced emission (AIE) luminogens with living bacteria to create bionic hybrid robots for multimodal phototheranostics and immunotherapy. This groundbreaking approach, detailed in his 2025 highly cited paper (37 citations), overcomes the limitations of conventional photosensitizers by combining multiple photosensitizing mechanisms within a single molecular system. Wang’s major contribution lies in engineering these bacteria-based “living” robots that can precisely target tumors, enabling simultaneous photodynamic and photothermal therapy while activating the immune system—a true “one-and-done” strategy. His work has garnered significant attention for its potential to revolutionize cancer treatment by enhancing therapeutic efficacy and reducing side effects. Through this innovative fusion of materials science, microbiology, and oncology, Wang is establishing himself as a rising leader in the field of smart, biohybrid therapeutic platforms.

Research Focus

Key Achievements

1
H-Index
1
Papers
37
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Aggregation induced emission luminogen bacteria hybrid bionic robot for multimodal phototheranostics and immunotherapy
37 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Huzhou University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago